Unlock instant, AI-driven research and patent intelligence for your innovation.

Application of paclitaxel combined with vinpocetine in preparation of medicine for treating lung cancer

A combined drug and paclitaxel technology, which is applied in the field of medicine, can solve the problems that have not yet been reported, and achieve the effect of improving anti-tumor effect and reducing toxic and side effects

Inactive Publication Date: 2021-08-06
阿耳法猫(杭州)人工智能生物科技有限公司
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] There are no reports on the combined effects of paclitaxel and vinpocetine

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of paclitaxel combined with vinpocetine in preparation of medicine for treating lung cancer
  • Application of paclitaxel combined with vinpocetine in preparation of medicine for treating lung cancer

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0017] Embodiment 1 mouse pdx model is established

[0018] 1. Experimental materials

[0019] Matrigel® Matrix matrigel (Corning, USA), RPMI 1640 medium (Biological Industries, Israel), lung cancer human tumor tissue.

[0020] 2. Tumor tissue inoculation

[0021] 1. Thaw the Matrigel and mix it with 1640 medium at a ratio of 1:1 to dilute it, and put it on ice for later use.

[0022] 2. Dissect the human-derived tumor that has grown to a sufficient volume under the skin of nude mice and place it in a petri dish. Place the dish on ice and pour an appropriate amount of pre-cooled physiological saline.

[0023] 3. Carefully remove the necrotic part of the tumor tissue, blood vessels and tumor surface capsule, etc.

[0024] 4. Cut tumor tissue into 1 mm 3 Small pieces of about volume are mixed with diluted Matrigel for later use.

[0025] 5. Using a trocar, implant the small tumor mass mixed with Matrigel subcutaneously in the right side of the nude mouse.

[0026] 6. After...

Embodiment 2

[0027] Example 2 Changes in volume of transplanted tumor in mice

[0028] 1. Experimental group

[0029] 1. Blank group: no administration.

[0030] 2. Paclitaxel group: Paclitaxel 5 mg / kg was administered intravenously once.

[0031] 3. Vinpocetine group: Vinpocetine 3 mg / kg, intraperitoneal injection once.

[0032] 4. Combined drug group: paclitaxel administered by intravenous injection, 5 mg / kg, once; vinpocetine administered by intraperitoneal injection, 3 mg / kg, once.

[0033] 2. Results Analysis

[0034] The diameter of the tumor was measured before the administration started, and the diameter of the tumor was measured every 2 days thereafter until the end of the experiment. The mice were sacrificed by devertebral dissection the next day after the administration, and the subcutaneous tumor tissues were dissected and photographed.

[0035] Table 1 Changes in the volume of transplanted tumors in mice in each group

[0036] group Day 0 (mm 3 )

[0037] a...

Embodiment 3

[0038] Example 3 Tumor pathological HE staining

[0039] 1. HE staining

[0040] The dissected subcutaneous tumor tissues were fixed with fixative and prepared into paraffin sections. Dewax with xylene I, II and III for 3 minutes each, ethanol I and II for 2 minutes each, 95% ethanol, 90% ethanol, and 80% ethanol for 1 minute each, stain with hematoxylin for 10 minutes, and rinse with water 1% hydrochloric acid alcohol differentiation for 15 seconds, soaking in water for 10 minutes, eosin staining for 3 minutes, 80% ethanol and 90 ethanol for 10 seconds each, 95% ethanol for 1-2 minutes, absolute ethanol I, II, III for 3 minutes each, two Toluene I, II, III each for 3 minutes, and finally neutral gum sealing, photographed under a microscope.

[0041] 2. Results Analysis

[0042] according to figure 2 The displayed staining results show that the nuclear staining of the tumor cells in the blank group, the paclitaxel group and the vinpocetine group is obviously darker, the n...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention belongs to the field of medicine, and particularly relates to application of paclitaxel combined with vinpocetine in preparation of a medicine for treating lung cancer. The application of paclitaxel combined with vinpocetine in preparation of a medicine for treating lung cancer is provided for the first time, the paclitaxel and the vinpocetine have an obvious synergistic effect, effectively improve curative effect, which is more significant than that of a single component, and improve lethality of tumor cells; effectively reduce dosage, thereby reducing toxic and side effects. The combined use of the two can save cost, reduce economic burden of patients, provides a new way for prevention and treatment of lung cancer, and has wide application prospects in the field of medicine and pharmacology.

Description

Technical field: [0001] The invention belongs to the field of medicine, in particular to the application of paclitaxel and vinpocetine in the preparation of drugs for treating lung cancer. Background technique: [0002] Lung cancer, short for "primary bronchial lung cancer", is a malignant tumor originating from respiratory epithelial cells (bronchi, bronchioles and alveoli). According to tissue lesions, it can be divided into small cell carcinoma and non-small cell carcinoma. Lung cancer has a high incidence rate, high mortality rate, high growth rate, and low cure rate. Surgery is the most effective treatment for patients with early-stage lung cancer, but most patients are diagnosed at an advanced stage. Chemotherapy is the main treatment for metastatic lung cancer, but it will cause serious side effects and drug resistance. Even with the advances in molecular targeted therapy for lung cancer today, the overall 5-year survival rate of lung cancer is still lower than 20%...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/4375A61K31/337A61P11/00A61P35/00
CPCA61K31/337A61K31/4375A61P11/00A61P35/00A61K2300/00
Inventor 李斌
Owner 阿耳法猫(杭州)人工智能生物科技有限公司